52
Views
6
CrossRef citations to date
0
Altmetric
Review

Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients

, &
Pages 789-796 | Published online: 08 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pravinkumar Vishwanath Ingle, Sarah Zakiah Samsudin, Pei Qi Chan, Mei Kei Ng, Li Xuan Heng, Siu Ching Yap, Amy Siaw Hui Chai & Audrey San Ying Wong. (2016) Development and novel therapeutics in hepatocellular carcinoma: a review. Therapeutics and Clinical Risk Management 12, pages 445-455.
Read now

Articles from other publishers (5)

Douglas Dieterich, Mark Nelson, Vicente Soriano, Keikawus Arastéh, Josep M. Guardiola, Jürgen K. Rockstroh, Sanjay Bhagani, Montserrat Laguno, Cristina Tural, Patrick Ingiliz, Mamta K. Jain, Jerry O. Stern, Montserrat Manero, Richard Vinisko & Jens Kort. (2015) Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV. AIDS 29:5, pages 571-581.
Crossref
Joachim Bräutigam, Axel J Scheidig & Wolfgang Egge-Jacobsen. (2013) Mass spectrometric analysis of hepatitis C viral envelope protein E2 reveals extended microheterogeneity of mucin-type O-linked glycosylation. Glycobiology 23:4, pages 453-474.
Crossref
Jie Wang, Hong-sheng Lin, Meng-yu Liu & Yong Li. (2010) Immune reconstitution of acquired immune deficiency syndrome. Chinese Journal of Integrative Medicine 16:6, pages 557-564.
Crossref
Andrés Duarte-Rojo & E. Jenny Heathcote. (2010) Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B. Therapeutic Advances in Gastroenterology 3:2, pages 107-119.
Crossref
Jillian Whidby, Guaniri Mateu, Hannah Scarborough, Borries Demeler, Arash Grakoui & Joseph Marcotrigiano. (2009) Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain. Journal of Virology 83:21, pages 11078-11089.
Crossref